Lexicon Pharmaceuticals Inc (NASDAQ:LXRX)

1.74
Delayed Data
As of May 27
 +0.06 / +3.57%
Today’s Change
1.56
Today|||52-Week Range
6.33
-55.84%
Year-to-Date
Largest transactions by value over  
NameTypeDateShares
traded
Share
price
Transaction
value
Since
transaction
Coats Lonnel
Chief Executive Officer
Sale2/28/202248,053$2.85$137.0K-15.94%
Wade Jeffrey L
President & Chief Financial Officer
Sale2/28/202225,773$2.85$73.5K-15.94%
Main Alan J
Sale2/28/202219,756$2.85$56.3K-15.94%
Crum Brian T
General Counsel & Senior Vice President
Sale2/28/202215,059$2.85$42.9K-15.94%
Kassler Taub Kenneth B
SVP-Regulatory Affairs & Quality Assurance
Sale2/28/202213,241$2.85$37.7K-15.94%
Seth Kiernan A
Chief Commercial Officer & Vice President
Sale2/28/20228,261$2.85$23.5K-15.94%
Alexander Kristen L
Vice President-Finance & Accounting
Sale2/28/20223,337$2.85$9.5K-15.94%
Sobecki Christopher J
Director
Gift7/01/20215,700$0.00$0.00-60.09%
Coats Lonnel
Chief Executive Officer
Buy2/28/202279,380$0.00$0.00-15.94%
Coats Lonnel
Chief Executive Officer
Buy2/28/202284,630$0.00$0.00-15.94%
Page of 4